Your browser doesn't support javascript.
loading
The impact of age, disease severity, and BMI on bone health and growth in children and young people with Crohn's disease.
Kherati, Rida; Bansal, Archana; Oleksiewicz, Julia; Kadir, Ahmed; Burgess, Natasha; Barr, Sabrina; Naik, Sandhia; Croft, Nicholas M; Gasparetto, Marco.
Afiliação
  • Kherati R; Queen Mary University of London Barts and The London School of Medicine and Dentistry London UK.
  • Bansal A; Department of Paediatric Gastroenterology, Clinical Research Facility, Barts Health NHS Trust The Royal London Children's Hospital London UK.
  • Oleksiewicz J; Department of Paediatric Gastroenterology, Barts Health NHS Trust The Royal London Children's Hospital London UK.
  • Kadir A; Department of Paediatric Gastroenterology, Barts Health NHS Trust The Royal London Children's Hospital London UK.
  • Burgess N; Department of Paediatric Gastroenterology, Barts Health NHS Trust The Royal London Children's Hospital London UK.
  • Barr S; Department of Paediatric Gastroenterology, Barts Health NHS Trust The Royal London Children's Hospital London UK.
  • Naik S; Department of Paediatric Gastroenterology, Barts Health NHS Trust The Royal London Children's Hospital London UK.
  • Croft NM; Queen Mary University of London Centre for Immunobiology, The Blizard Institute London UK.
  • Gasparetto M; Department of Paediatric Gastroenterology, Barts Health NHS Trust The Royal London Children's Hospital London UK.
JPGN Rep ; 5(1): 17-28, 2024 Feb.
Article em En | MEDLINE | ID: mdl-38545265
ABSTRACT

Objectives:

The objective of this study was to explore the correlation between paediatric Crohn's disease (CD) characteristics, bone health and growth parameters at diagnosis and follow-up.

Methods:

Retrospective data was collected for 47 children aged 4-16 who were newly diagnosed with CD between January 2018 and December 2019. Mean follow-up time was 2.5 years.

Results:

Eleven (24%) children had growth delay at diagnosis, which persisted in 4 (44%) of 9 recorded children at follow-up. Of the 35 children tested, 20 (57%) had inadequate Vitamin D levels (<50 mmol/L) at diagnosis. Thirty-seven (79%) children had a dual-energy X-ray absorptiometry scan at diagnosis, with 20 of them having at least 1 low Z-score. Children with poorer bone mineral density and bone mineral concentration Z-scores for age had a younger age at diagnosis (p = .042 and p = .021), more severe disease (p = .04 and p = .029) and a lower BMI (p < .001) at diagnosis. Children diagnosed with CD ≥11 years had a lower-than-expected height velocity (p < .0001 and p < .001). Multivariate regression analysis demonstrated an older age of diagnosis was a significant predictor of a lower height velocity at follow-up.

Conclusion:

Disease severity and age of diagnosis are important CD-related factors that influence bone health and growth. Vitamin D is an accessible component that if optimised can improve all three factors. Monitoring and optimising each aspect systematically has the potential to enable children to achieve their bone health and growth potentials.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article